Cochlear Management

Management criteria checks 4/4

Cochlear's CEO is Dig Howitt, appointed in Jul 2017, has a tenure of 7.33 years. total yearly compensation is A$6.45M, comprised of 32.1% salary and 67.9% bonuses, including company stock and options. directly owns 0.094% of the company’s shares, worth $12.22M. The average tenure of the management team and the board of directors is 7.3 years and 4.8 years respectively.

Key information

Dig Howitt

Chief executive officer

AU$6.4m

Total compensation

CEO salary percentage	32.1%
CEO tenure	7.3yrs
CEO ownership	0.09%
Management average tenure	7.3yrs
Board average tenure	4.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Dig Howitt's remuneration changed compared to Cochlear's earnings?
Date	Total Compensation	Salary	Company Earnings
Jun 30 2024	AU$6m	AU$2m	AU$357m
Mar 31 2024	n/a	n/a	AU$354m
Dec 31 2023	n/a	n/a	AU$350m
Sep 30 2023	n/a	n/a	AU$326m
Jun 30 2023	AU$6m	AU$2m	AU$301m
Mar 31 2023	n/a	n/a	AU$281m
Dec 31 2022	n/a	n/a	AU$261m
Sep 30 2022	n/a	n/a	AU$275m
Jun 30 2022	AU$5m	AU$2m	AU$289m
Mar 31 2022	n/a	n/a	AU$273m
Dec 31 2021	n/a	n/a	AU$257m
Sep 30 2021	n/a	n/a	AU$291m
Jun 30 2021	AU$5m	AU$2m	AU$324m
Mar 31 2021	n/a	n/a	AU$82m
Dec 31 2020	n/a	n/a	-AU$160m
Sep 30 2020	n/a	n/a	-AU$199m
Jun 30 2020	AU$3m	AU$2m	-AU$238m
Mar 31 2020	n/a	n/a	AU$34m
Dec 31 2019	n/a	n/a	AU$306m
Sep 30 2019	n/a	n/a	AU$291m
Jun 30 2019	AU$4m	AU$2m	AU$277m
Mar 31 2019	n/a	n/a	AU$270m
Dec 31 2018	n/a	n/a	AU$264m
Sep 30 2018	n/a	n/a	AU$255m
Jun 30 2018	AU$3m	AU$2m	AU$246m

Compensation vs Market: Dig's total compensation ($USD4.19M) is below average for companies of similar size in the US market ($USD12.64M).

Compensation vs Earnings: Dig's compensation has been consistent with company performance over the past year.

CEO

Dig Howitt (57 yo)

7.3yrs

Tenure

AU$6,446,856

Compensation

Mr. Diggory William Howitt, also known as Dig, BE (Hons), MBA has been President of Cochlear Limited since July 31, 2017 and its Chief Executive Officer and Managing Director since January 3, 2018. Mr. How...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Diggory Howitt	CEO, MD	7.3yrs	AU$6.45m	0.094% $ 12.2m
Stuart Sayers	Chief Financial Officer	8.5yrs	AU$2.46m	0.0052% $ 677.6k
Jan Janssen	Chief Technology Officer	7yrs	AU$2.66m	0.0093% $ 1.2m
Karen O'Driscoll	Chief Information Officer	1.8yrs	no data	no data
Kristina Devon	Vice President of Investor Relations	no data	no data	no data
Rob McGrory	Group General Counsel & Company Secretary	1.2yrs	no data	no data
Jennifer Stevenson	VP of Corporate Communications & Brand	no data	no data	no data
Dean Phizacklea	Senior Vice President of Global Strategic Marketing	8.4yrs	no data	no data
Jennifer Hornery	Senior Vice President of Global People & Culture	7.8yrs	no data	no data
Greg Bodkin	Senior Vice President of Global Supply Chain	no data	no data	no data
Anthony Bishop	President of Asia Pacific & Latin America	no data	AU$1.45m	no data
Kimberley Simpson	Head of Group Tax	no data	no data	no data

7.3yrs

Average Tenure

Experienced Management: CHEO.Y's management team is seasoned and experienced (7.3 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Diggory Howitt	CEO, MD	7yrs	AU$6.45m	0.094% $ 12.2m
Michael Daniell	Independent Non-Executive Director	4.8yrs	AU$295.72k	0.0025% $ 321.2k
Catriona Deans	Independent Non-Executive Chairman of the Board	9.8yrs	AU$596.78k	0.0069% $ 894.8k
Bruce Robinson	Independent Non-Executive Director	7.9yrs	AU$269.01k	0.0018% $ 235.4k
Karen Lee Penrose	Non-Executive Independent Director	2.3yrs	AU$305.87k	0.0022% $ 282.2k
Glen Boreham	Independent Non-Executive Director	9.8yrs	AU$293.36k	0.0046% $ 599.6k
Michael J. Del Prado	Independent Non-Executive Director	2.8yrs	AU$314.99k	0.0014% $ 187.3k
Christine McLoughlin	Independent Non-Executive Director	4yrs	AU$287.65k	0.0037% $ 477.3k
Caroline Clarke	Non-Executive Director	less than a year	no data	no data

4.8yrs

Average Tenure

61yo

Average Age

Experienced Board: CHEO.Y's board of directors are considered experienced (4.8 years average tenure).

Cochlear Management

Management criteria checks 4/4

Key information

Recent management updates

Stu Sayers to Appoint as President, Asia Pacific & Latin America of Cochlear Limited, Effective from 1 January 2025

Cochlear Limited Appoints Caroline Clarke as Non-Executive Director, Effective from 2 September 2024

Cochlear Limited Announces Executive Changes

Cochlear Limited Announces Company Secretary Changes

Cochlear Limited Announces Andrew Denver, Non-Executive Director Intention to Retire At AGM to Be Held on 17 October 2023

Cochlear Limited, Annual General Meeting, Oct 17, 2023

Recent updates

Stu Sayers to Appoint as President, Asia Pacific & Latin America of Cochlear Limited, Effective from 1 January 2025

Cochlear Limited Announces Ordinary Dividend for the Period of Six Months Ended June 30, 2024, Payable on October 10, 2024

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Cochlear Limited Appoints Caroline Clarke as Non-Executive Director, Effective from 2 September 2024

Cochlear Limited Announces Executive Changes

Cochlear Limited (ASX:COH) acquired Oticon Medical A/s from Demant A/S (CPSE:DEMANT).

Cochlear Limited Announces Company Secretary Changes

Cochlear Limited Receives Fda Clearance to Lower the Age for the Osia System to 5-Year-Old

Cochlear Limited Introduces Next Generation Cochlear Osia System with Ability to Have MRI at 3.0 T

Cochlear Limited to Report Fiscal Year 2024 Results on Aug 15, 2024

Cochlear Limited Announces Andrew Denver, Non-Executive Director Intention to Retire At AGM to Be Held on 17 October 2023

Cochlear Limited Provides Earnings Outlook for the Year 2023

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Cochlear Limited, Annual General Meeting, Oct 17, 2023

FDA Approves Cochlear Limited's Nucleus 8 Sound Processor, Smaller, Smarter, Better Connected Cochlear Implant Technology

Cochlear Announces Final Dividend Payable on 17 October 2022

Cochlear Limited Appoints Karen Penrose to Board, Effective on 1 July 2022

Cochlear Limited, Annual General Meeting, Oct 18, 2022

Cochlear Limited to Report First Half, 2023 Results on Feb 15, 2023

Cochlear Limited Announces Interim Dividend Expected to Be Payable on 21 April 2022

FDA Approves Cochlear Nucleus Implants for Unilateral Hearing Loss/Single-Sided Deafness

Cochlear Limited Advises of US Patent Infringement Complaint

Sensorion and Cochlear to Begin First Clinical Trial of SENS-401 for Hearing Preservation in Combination with Cochlear Implantation

Cochlear Limited Provides Earnings Guidance for the Fiscal Year 2022

New Cochlear CoPilot app to help adults improve hearing outcomes through skills training

Cochlear Receives FDA Clearance of Baha 6 Max, Industry's Smallest 55 dB Sound Processor Now with Direct Android Streaming

Cochlear Limited Receives US Food and Drug Administration Approval for Baha 6 Max Sound Processor

Cochlear Limited Appoints Stu Sayers as Chief Financial Officer

Cochlear Limited Appoints Stu Sayers as Acting CFO

Cochlear Limited Appoints Stephen Mayne as Director

Cochlear Limited to Report Fiscal Year 2021 Results on Aug 20, 2021

Cochlear Limited to Report Fiscal Year 2020 Results on Aug 18, 2020

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Board Members

Average Tenure

Average Age